ClinicalTrials HQ

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Recruiting · NCT05093231 · Registry updated 2026-06-17
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasmRecruitingPhase 22026-06-17NCT05093231

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cambridge University Hospitals NHS Foundation Trust64
National Institute for Health Research, United Kingdom75

17 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Addenbrooke's HospitalCambridgeUnited Kingdom14
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom18
Clatterbridge Cancer CentreLiverpoolUnited Kingdom4
Derriford HospitalPlymouthUnited Kingdom27
Epworth HealthcareRichmondAustralia4
Glan Clwyd HospitalBodelwyddanUnited Kingdom4
Guy's and St Thomas' NHS Foundation TrustLondonUnited Kingdom26
Milton Keynes University HospitalMilton KeynesUnited Kingdom6
Monash HealthMelbourneAustralia1
Norfolk and Norwich University HospitalNorwichUnited Kingdom11
Nottingham University Hospitals NHS Foundation TrustNottinghamUnited Kingdom1
Royal Free HospitalLondonUnited Kingdom24
St James' University HospitalLeedsUnited Kingdom2
The ChristieManchesterUnited Kingdom7
University College London Hospitals NHS Foundation TrustLondonUnited Kingdom16
University Hospitals Coventry and WarwickshireCoventryUnited Kingdom3
Velindre Cancer CentreCardiffUnited Kingdom32